Navigation Links
GENova Biotherapeutics signs engagement agreement with PacificWave Partners Limited
Date:9/16/2009

NEW YORK, NY, Sept. 16 /PRNewswire-FirstCall/ - (OTCBB: GVBP.OB) - GENova Biotherapeutics Inc. ("GENova"), a biotechnology company that develops novel therapeutic proteins that disrupt the advance of life-threatening cancers, today announced it has signed an engagement agreement with PacificWave Partners Limited ("PacWave") for raising a minimum of USD5m to the company as well as actively look for potential buy-out and/or acquisition targets.

The deal will entail an upcoming visit to the US where the management team will be meeting hedge funds and institutional investors, PacWave is confident that with the strength of the management team as well as the liquidity in the company's stock that financing can be secured within a timely fashion and under very favorable terms.

In addition to the fund raising effort, PacWave will approach a number of major pharma companies which are currently active making acquisitions of smaller biotech companies and position GENova as a potential next acquisition target.

About PacificWave Partners Limited

PacificWave Partners is a privately held international financial advisory firm providing investment banking services to privately-held and publicly-traded micro, small and mid capitalization companies throughout Asia, Europe and North America. PacificWave is headquartered in Copenhagen, Denmark with offices in San Francisco, Los Angeles and New York and specializes in capital raises between USD5m - USD50m

About GENova Biotherapeutics Inc.

GENova is positioning itself as the world's leading bioscience company in the development and commercial licensing of novel therapeutic proteins that disrupt the advance of life-threatening cancers. The company leverages cutting-edge research collaborations to achieve breakthroughs in anti-cancer treatments, and then licenses these drug product candidates to Big Pharmaceutical and Biotechnology companies such as Pfizer, Amgen, Myriad Genetics, Medarex, and Biogen Idec.

Forward Looking Statements

This document includes certain statements that may be deemed to be "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, are expected by the Company to be forward-looking statements. Although GENova believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in the forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include but are not limited to the success of the owned intellectual property, the strength of the patents, continued availability of capital and financing, and general economic market or business conditions.


'/>"/>
SOURCE GENova Biotherapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. GENova and TheraGlass in advanced negotiations
2. GENova Biotherapeutics forming academic partnerships
3. GENova Biotherapeutics signs collaboration agreement with Prime BioResearch
4. GENova Biotherapeutics and Prime BioResearch signs LOI on diabetes and cancer cure
5. GENova gains access to Big Pharma
6. GENova appoints Dr. Wang Chong to Scientific Advisory Board
7. GENova appoints Dr. Philip Gould to Scientific Advisory Board
8. GENova issues clarifying press release
9. GENova to acquire three new drug target patents worth in excess of $1 billion in royalty fees
10. GENova files patent for new breast cancer treatment
11. GENova appoints Director of Asian business development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... Louisiana (PRWEB) , ... January 17, 2017 , ... ... Senior Medical Center joined the Peoples Health network on Dec. 1, 2016. ... beneficiaries. , “JenCare Senior Medical Center is an exciting addition to our provider ...
(Date:1/17/2017)... Livingston, NJ (PRWEB) , ... January 17, 2017 , ... ... services and financial planning assistance to communities throughout the region, is launching a charity ... , Heart disease is by far the deadliest killer in America, and is responsible ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... eliminate cyber threats in real-time, today announced a strategic partnership with TechLab ... Malaysia. Joining other Seceon partners, TechLab Security has become a strategic partner and ...
(Date:1/17/2017)... ... January 17, 2017 , ... Many people make New Year’s resolutions or renew their ... is making it easier for people who want to kick off 2017 with better ... existing patients. , These special offers include: , , A ...
(Date:1/16/2017)... (PRWEB) , ... January 17, 2017 , ... Recently, patients ... in Southwest Michigan, joined other volunteers and organizations in support of the annual Binder ... children and families dressed up in colorful costumes of all designs coming out to ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... -- From the company that brought a full line of equine first ... new line of companion animal pet first aid kits.  EquiMedic ... aid, has developed two sizes of small pet first aid kits ... Featuring a small and a large companion pet first aid ... not a newcomer to working with small animals either. Corporate owners, ...
(Date:1/17/2017)... HOUSTON , Jan. 17, 2017  OrthoAccel ® ... Clinical Orthodontics (JCO) has published "The Effect of ... adolescent patients. Conducted by Dr. S. Jay Bowman ... treating Class II malocclusions, AcceleDent,s SoftPulse Technology ® ... crown while also reducing the number of days to ...
(Date:1/17/2017)... -- Research and Markets has announced the addition of ... to their offering. ... The global fluoropolymer market in the healthcare industry to grow ... Global Fluoropolymer Market in the Healthcare Industry 2016-2020, has been ... experts. The report covers the market landscape and its growth prospects ...
Breaking Medicine Technology: